Document is current
Any future updates will be listed below
-
Authors
Perrin, Germain https://orcid.org/0000-0002-5330-1777
Thomas-Schoemann, Audrey https://orcid.org/0000-0002-8240-1478
Goldwasser, François https://orcid.org/0000-0003-1503-0723
Boudou-Rouquette, Pascaline https://orcid.org/0000-0002-4860-305X
Delanoy, Nicolas https://orcid.org/0000-0002-8286-7868
Gervais, Claire https://orcid.org/0000-0002-0569-692X
Touchard, Justine https://orcid.org/0000-0001-6573-8506
Batista, Rui https://orcid.org/0000-0002-9273-3644
Blanchet, Benoit https://orcid.org/0000-0003-3096-4305
Giraud, Jean-Stéphane https://orcid.org/0000-0001-9160-0842
Sabatier, Brigitte https://orcid.org/0000-0003-1643-2070
Korb-Savoldelli, Virginie https://orcid.org/0000-0003-3496-6244
-
Funding
Funding for this research was provided by:
Grant “Direction Générale de l’Offre de Soins” for the implementation of clinical pharmacy activities in French hospitals
- License Information
-
More Information
Article History
Received: 19 March 2025
Accepted: 28 September 2025
First Online: 15 October 2025
Declarations
:
: The study was conducted in accordance with good clinical practice guidelines for biomedical studies [] and French regulations. The study protocol, patient-information note, and non-opposition consent form were approved by an ethics committee (CERAPHP 22/07/19, n°IDRCB 2018-AO3512-53).
: All eligible patients agreed to participate in the study and signed a non-opposition consent form.
: The authors declare no competing interests.
